Skip to content

PTSD: all studies

Page 142 of 211: studies 1,411 to 1,420 of 2,103, newest first. Back to the PTSD overview

Research

An examination of internal family systems interventions for trauma with implications for ethical psychedelic-assisted treatment

Journal of Psychedelic Studies March 5, 2024 Mitch Earleywine, Alyssa B. Oliva, Joseph A. de Leo et al. 6 citations

Though several treatments effectively address the pervasive impact of trauma, they do not achieve complete symptom resolution for all clients, inspiring the search for alternatives. Internal Family Systems (IFS) therapy has grown popular, especially in informal psychedelic-assisted treatments (PAT). Compared to stereotypes of empirically validated, exposure-based treatments, IFS has novel...

Psychedelic Therapy: A Primer for Primary Care Clinicians—Ibogaine

American Journal of Therapeutics March 1, 2024 Kirsten Cherian, Kenneth Shinozuka, Burton J. Tabaac et al. 9 citations

BACKGROUND: Ibogaine is a plant-derived alkaloid that has been used for thousands of years in rites of passage and spiritual ceremonies in West-Central Africa. In the West, it has primarily been used and studied for its anti-addictive properties and more recently for other neuropsychiatric indications, including post-traumatic stress disorder, depression, anxiety, and traumatic brain injury....

MDMA enhances positive affective responses to social feedback.

Journal of Psychopharmacology March 1, 2024 Anya K. Bershad, David T Hsu, Harriet de Wit 9 citations

The prosocial compound ± 3,4-methylenedioxymethamphetamine (MDMA) is an amphetamine derivative that has shown promise as an adjunct to psychotherapy in the treatment of post-traumatic stress disorder. MDMA increases positive responses to social images, and it has been suggested that the ability of MDMA to positively bias social perception may underlie its therapeutic efficacy as a psychotherapy...

DOI: 10.1177/02698811231224153 (opens in new tab) Full text (opens in new tab) MDMA Social acceptance Social feedback Social rejection

Recreational MDMA doses do not elicit hepatotoxicity in HepG2 spheroids under normo- and hyperthermia.

Toxicology March 1, 2024 Arthur L. De Oliveira, Raul G Miranda, Daniel J Dorta 1 citation

MDMA (3,4-methylenedioxymethamphetamine), an entactogen with empathogenic and prosocial effects, is widely used in music festivals and other festive settings. High MDMA doses have been associated with drug-induced liver injury and cases of hyperthermia. Although the latter condition is thought to increase MDMA hepatotoxicity, this correlation remains poorly explored for recreational MDMA doses....

DOI: 10.1016/j.tox.2024.153761 (opens in new tab) Full text (opens in new tab) Tridimensional cell culture Drug research MDMA/Ecstasy/Molly/E Liver toxicity/hepatotoxicity/citotoxicity

The Clinical Potential of Dimethyltryptamine: Breakthroughs into the Other Side of Mental Illness, Neurodegeneration, and Consciousness

Psychoactives February 26, 2024 Frankie A. Colosimo, Philip Borsellino, Reese I. Krider et al. 8 citations

The human brain is an extraordinarily complex organ responsible for all aspects of cognition and control. Billions of neurons form connections with thousands of other neurons, resulting in trillions of synapses that create a vast and intricate network. This network is subjected to continuous remodeling that adapts to environmental and developmental changes. The resulting neuroplasticity is...

Cannabis and Anxiety: A Critical Review

Medical Cannabis and Cannabinoids February 23, 2024 Alexander Beletsky, Cherry Liu, Bryson Lochte et al.

Abstract Introduction: Cannabis has been reported to have both anxiogenic and anxiolytic effects. Habitual cannabis use has been associated with anxiety disorders (AD). The causal pathways and mechanisms underlying the association between cannabis use (CU)/cannabis use disorder (CUD) and anxiety remain unclear. We examined the literature via a systematic review to investigate the link between...

Decreased CO2 saturation during circular breathwork supports emergence of altered states of consciousness

Research Square February 22, 2024 Martha N. Havenith, Max Leidenberger, Jelena Brasanac et al. 3 citations preprint

Abstract Altered states of consciousness (ASCs), induced e.g. by psychedelics, show great potential to treat widespread mental health disorders like depression and PTSD. However, access to such treatments is restricted by legal, medical, and financial barriers. Here, we explore the potential of circular breathwork to serve as an accessible, non-pharmacological alternative to engage similar...

DOI: 10.21203/rs.3.rs-3976380/v1 (opens in new tab) Non-ordinary states Circular breathwork Respiration Breathing techniques +14

Uncovering Structure-Activity Relationships of Phenethylamines: Paving the Way for Innovative Mental Health Treatments.

ACS Chemical Neuroscience February 21, 2024 Sedat Karabulut, Harpreet Kaur, James W Gauld

The rapidly evolving psychedelic industry has garnered considerable attention due to 3,4-methylenedioxymethamphetamine-assisted psychotherapy's ground-breaking success in treating moderate-to-severe Post-traumatic Stress Disorder in two Phase 3 clinical trials. This has opened Pandora's box for the development of innovative therapeutic modalities. Of particular interest are the phenethylamines...

Defining 5-MeO-DMT in Historical and Cultural Contexts

World Futures February 17, 2024 Azul Delgrasso 4 citations

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychedelic and entheogenic compound that has been used for centuries by Indigenous Peoples in the Amazon, Caribbean, and more recently in communities in Northern Mexico in ceremonial practices and to connect with nature. In recent years, there has been growing interest in 5-MeO-DMT to treat mental health conditions such as depression, anxiety...

DOI: 10.1080/02604027.2024.2330255 (opens in new tab) Radical photochemical reactions Alkaloids

Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain.

AJNR. American journal of neuroradiology February 15, 2024 Paloma C Frautschi, Ajay P Singh, Nicholas A Stowe et al. 5 citations

The neurobiological mechanisms underpinning psychiatric disorders such as treatment-resistant major depression, post-traumatic stress disorder, and substance use disorders, remain unknown. Psychedelic compounds, such as psilocybin, lysergic acid diethylamide, and N,N-dimethyltryptamine, have emerged as potential therapies for these disorders because of their hypothesized ability to induce...

DOI: 10.3174/ajnr.a8118 (opens in new tab) Full text (opens in new tab) Psychedelics Mental health Brain research Therapeutic medicine